KUALA LUMPUR: Hong Leong Investment Bank (HLIB) Research is retaining its overweight stance on glove makers as it sees demand and average selling prices (ASPs) will be driven by testing frequency and vaccine rollout using gloves.
In its research note on Tuesday, it said for the remainder of CY21, it expects vaccination demand for gloves to more than offset the decline from testing demand.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
